# SGS North America Inc. – FDA Inspection, Aug 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/c6f19e1c-ac16-4775-b564-beda8746d962
Source feed: FDA_Inspections

> FDA inspection 1211177 of SGS North America Inc., August 01, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211177
- Company Name: SGS North America Inc.
- Inspection Date: 2023-08-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1321138 - 2026-06-09](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/19f7bf6c-95d5-4ab7-b207-dd53edeedef6)
- FDA Inspection 1027721 - 2017-08-30
- [FDA Inspection 973286 - 2016-06-07](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/4e004227-2261-4022-b159-d244067595d6)
- [FDA Inspection 862181 - 2014-01-21](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/7be923bd-27ee-433c-9070-d1f7d294e919)
- FDA Inspection 753526 - 2011-11-21

## Related Officers

- [Amatul H. Marium](https://www.keypedia.com/people/amatul-h-marium/5db400ce-ffde-4310-82f8-766fd2458a4d)
- [Company Rep](https://www.keypedia.com/people/anthony-j-donato/a6dd6e14-529e-4b23-9b5f-02c88afb80ae)
- [FDA Associated Person](https://www.keypedia.com/people/victoria-spivak/b43d066f-35c1-4d83-9d38-3ba64d77cf31)

Company: https://www.keypedia.com/companies/sgs-north-america-inc/2ab4b437-f0ec-4f38-a8bc-88a319e32f4d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
